Edwards Lifesciences Corporation
EW
$68.51
$0.120.18%
Weiss Ratings | EW - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | C | |||
Rating Factors | EW - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Good | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | EW - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.36 | |||
Price History | EW - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -4.03% | |||
30-Day Total Return | -5.58% | |||
60-Day Total Return | -7.18% | |||
90-Day Total Return | -1.24% | |||
Year to Date Total Return | -5.62% | |||
1-Year Total Return | -24.64% | |||
2-Year Total Return | -10.58% | |||
3-Year Total Return | -33.00% | |||
5-Year Total Return | 9.90% | |||
52-Week High % Change | -28.85% | |||
52-Week Low % Change | 16.05% | |||
Price | EW - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $96.12 | |||
52-Week Low Price | $58.93 | |||
52-Week Low Price (Date) | Jul 25, 2024 | |||
52-Week High Price (Date) | Mar 28, 2024 | |||
Valuation | EW - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 40.21B | |||
Enterprise Value | 36.99B | |||
Price/Earnings (TTM) | 9.80 | |||
Earnings Per Share (TTM) | 6.98 | |||
Earnings Per Share Growth | 203.60% | |||
Price/Earnings To Growth | 0.05 | |||
Price/Sales (TTM) | 7.42 | |||
Price/Book (Q) | 4.03 | |||
Enterprise Value/Revenue (TTM) | 6.80 | |||
Price | $68.51 | |||
Enterprise Value/EBITDA (TTM) | 22.61 | |||
Enterprise Value/EBIT | 24.98 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | EW - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 590.50M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | EW - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 949 250 2500 | |||
Address | One Edwards Way Irvine, CA 92614 | |||
Website | www.edwards.com | |||
Country | United States | |||
Year Founded | 1958 | |||
Profitability | EW - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 27.22% | |||
Profit Margin | 76.74% | |||
Management Effectiveness | EW - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 8.26% | |||
Return on Equity | 16.64% | |||
Income Statement | EW - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 5.44B | |||
Total Revenue (TTM) | 5.44B | |||
Revenue Per Share | $9.21 | |||
Gross Profit (TTM) | 4.32B | |||
EBITDA (TTM) | 1.64B | |||
EBIT (TTM) | 1.48B | |||
Net Income (TTM) | 4.17B | |||
Net Income Avl. to Common (TTM) | 4.17B | |||
Total Revenue Growth (Q YOY) | 9.43% | |||
Earnings Growth (Q YOY) | 3.57% | |||
EPS Diluted (TTM) | 6.98 | |||
EPS Diluted Growth (Q YOY) | 7.08% | |||
Balance Sheet | EW - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 3.98B | |||
Cash Per Share (Q) | $6.73 | |||
Total Current Assets (Q) | 6.29B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 10.06B | |||
Current Ratio (Q) | 4.176 | |||
Book Value Per Share (Q) | $16.99 | |||
Total Assets (Q) | 13.06B | |||
Total Current Liabilities (Q) | 1.51B | |||
Total Debt (Q) | 700.00M | |||
Total Liabilities (Q) | 2.99B | |||
Total Common Equity (Q) | 10.00B | |||
Cash Flow | EW - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 2.31B | |||
Cash from Financing (TTM) | -983.00M | |||
Net Change in Cash (TTM) | 1.91B | |||
Levered Free Cash Flow (TTM) | 1.34B | |||
Cash from Operations (TTM) | 542.30M | |||